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     BSTRACT
Pyothorax, or thoracic empyema, is an infection of the pleural space, characterized by the 
accumulation of purulent exudate. It is a life-threatening emergency in dogs as well as in cats, 
with a guarded prognosis. Dyspnea and/or tachypnea, anorexia and lethargy are the most 
typical clinical signs. Diagnosis is usually straightforward, based on the clinical symptoms 
combined with pleural fluid analysis, including cytology and bacterial culture. Most commonly, 
oropharyngeal flora is isolated in the pleural fluid. Treatment can be medical or surgical, but 
needs to be immediate and aggressive. In this article, an overview of the various causes of both 
feline and canine pyothorax with its similarities and differences is provided. Epidemiology, 
symptoms, diagnosis, treatment and prognosis are discussed.
SAMENVATTING
Pyothorax, of thoraxempyeem, is een infectie van de pleurale holte, gekenmerkt door een accumu-
latie van purulent exudaat. Het is een levensbedreigende aandoening, zowel bij honden als bij kat-
ten, met een gereserveerde prognose. Dyspnee en/of tachypnee, anorexie en lethargie zijn de meest 
voorkomende symptomen. De diagnose is meestal gemakkelijk te stellen aan de hand van de klinische 
symptomen en onderzoek van het pleurale vocht, inclusief een cytologisch en bacteriologisch onder-
zoek. Meestal wordt orofaryngeale flora geïsoleerd in de pleurale effusie. De behandeling kan zowel 
medicamenteus als chirurgisch zijn, maar moet snel en agressief ingesteld worden. In dit artikel wordt 
een overzicht gegeven van de meest voorkomende oorzaken van zowel feliene als caniene pyothorax, 
waarbij gelijkenissen en verschillen worden besproken. Epidemiologie, klinische symptomen, diag-
nose, behandeling en prognose komen uitgebreid aan bod. 
A
INTRODUCTION
In dogs as well as in cats, pyothorax can be a 
life-threatening disease. It is defined as the presence 
of septic exudate in the pleural space (Ettinger and 
Feldman, 2010). Patients with pyothorax are usu-
ally presented with dyspnea and/or tachypnea and it 
might be difficult to determine the underlying cause 
straight away (Murphy and Papasouliotis, 2011a; 
Firth and Boag, 2012; Epstein, 2014). In general, the 
first step in dealing with dyspneic patients consists of 
providing a stress-free environment with sufficient 
oxygenation to maximize the breathing comfort of 
the animal. The clinical examination may have to be 
postponed, but a close inspection of the breathing pat-
tern will help in the initial localization of the problem 
(Beatty and Barrs, 2010; Murphy and Papasouliotis, 
2011a; Sigrist et al., 2011; Firth and Boag, 2012). On 
auscultation, pleural space disease is characterized by 
muffled heart and lung sounds. In case of pleural ef-
fusion, auscultation will be muffled ventrally, often in 
combination with increased lung sounds dorsally. The 
presence of air (pneumothorax) decreases dorsal lung 
sounds (Murphy and Papasouliotis, 2011a; Firth and 
Boag, 2012; Epstein, 2014). After initial stabilization, 
appropriate measures should be taken to relieve the 
discomfort of the animal. In many cases, immediate 
thoracocentesis is necessary (Beatty and Barrs, 2010; 
Firth and Boag, 2012). This may be therapeutic as 
well as diagnostic, because pleural fluid provides im-
184 Vlaams Diergeneeskundig Tijdschrift, 2017, 86
Figure 1. Flow chart for diagnostic and therapeutic management of pyothorax in dogs and cats.
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portant information concerning the underlying cause 
(Murphy and Papasouliotis, 2011a; Epstein, 2014). 
Although the diagnosis of pleural space disease 
and pleural effusion is usually straightforward, long-
term treatment may be more challenging and depends 
largely on the nature of the effusion (Murphy and Pa-
pasouliotis, 2011a; Epstein, 2014). In case of pyotho-
rax, pleural effusion is characterized by a septic exu-
date and medical management should at least consist 
of supportive care, systemic antibiotic therapy and 
drainage of the pleural fluid, which can be achieved 
through single or multiple thoracocenteses or through 
placement of thoracic drains, with or without thoracic 
lavage. Surgical management through thoracic sur-
gery or thoracoscopy may be necessary in selected 
cases (Rooney and Monnet, 2002; Swinbourne et al., 
2011). In this review, the general approach of pyotho-
rax in clinical practice is focussed upon (Figure 1). 
The basic epidemiology and pathophysiology are 
briefly explained to better understand clinical signs 
and diagnostic measures, and different treatment op-
tions are discussed to aid the clinician in making the 
best therapeutic choices for each patient individually.
EPIDEMIOLOGY 
Pyothorax is most frequently seen in middle-aged 
dogs and cats with a mean age of three to six years 
(Demetriou et al., 2002; Waddel et al., 2002; Barrs 
et al., 2005; Boothe et al., 2010). In some studies, 
outdoor male dogs and cats were more frequently af-
fected, probably because young, male animals have 
a greater likelihood to roam and fight, and therefore 
obtain penetrating injuries more easily (Demetriou 
et al., 2002; Waddel et al., 2002; Malik et al., 2006; 
Boothe et al., 2010). There is no clear data available 
concerning the actual incidence of pyothorax in dogs 
or in cats. Potential underlying causes include pene- 
trating trauma or bite wounds, migrating foreign 
bodies, parasites, neoplasia, hematogenous spread of 
extra-thoracic or intra-thoracic infections and iatro-
genic causes, e.g. thoracic surgery, thoracocentesis 
(Demetriou et al., 2002; Waddel et al., 2002; Barrs 
et al., 2005; Klainbart et al., 2005; Malik et al., 2006; 
Doyle et al., 2009; Boothe et al., 2010; Ettinger and 
Feldman, 2010).
In dogs, pyothorax is not frequently encountered 
(Piek and Robben, 2000; Rooney and Monnet, 2002; 
Johnson and Martin, 2007). The cause of pyothorax 
is only found in 2 to 19% of canine cases. The most 
common cause is the migration of foreign bodies. In 
40% of dogs with pyothorax that were managed surgi-
cally, a foreign body, e.g. grass awn, was the underly-
ing cause (Demetriou et al., 2002). The incidence and 
type of foreign bodies vary depending on the local 
geographical flora (Piek and Robben, 2000). English 
Springer spaniels, Border collies, Labrador retriev-
ers and their crosses are overrepresented due to their 
large airways, scenting habits, outdoor nature and thus 
frequent exposure to plant material (Demetriou et al., 
2002; Johnson and Martin, 2007; Doyle et al., 2009). 
Pyothorax is more frequently seen in cats than in 
dogs (Waddell et al., 2002; Barrs et al., 2005). A de-
finitive cause is found in 35 to 67% of feline cases. 
The most common route of infection is thought to be 
through penetrating bite wounds and abscesses that 
rupture towards the thoracic cavity, causing bacterial 
contamination and ultimately pyothorax. Data sup-
porting this hypothesis include a history of wounds 
in 14 to 40% of cases (Jonas, 1983; Waddell et al., 
2002), a seasonal association with more cases in late 
summer and fall due to increases in fighting behavior 
(Waddel et al., 2002; MacPhail, 2007) and the isola-
tion of similar bacteria in pyothorax as in bite wound 
abscesses (Waddell et al., 2002). Increased neutering, 
confinement and routine treatment with antibiotics af-
ter a catfight seem to reduce the incidence of pyotho-
rax (Barrs and Beatty, 2009a). Cats affected by pyo-
thorax are predominantly young outdoor cats from 
multi-cat households, probably because there is more 
inter-cat aggression (Waddel et al., 2002). However, 
these cats also have a greater exposure to upper respi-
ratory tract infections, which is a predisposing event 
in up to 26% of the feline pyothorax cases. In more 
recent studies, it has been suggested that aspiration 
of oropharyngeal flora with parapneumonic spread 
might be a more frequent cause of pyothorax than bite 
wounds (Waddell et al., 2002; Barrs et al., 2005; Barrs 
and Beatty, 2009a).
PATHOGENESIS AND CLINICAL SIGNS 
The pleural space and pathophysiology of pleural 
effusion
The pleural space is a potential space, lined by the 
visceral and parietal pleura. These serous membranes 
cover the outer surface of the lungs and inner surface 
of the thoracic cavity, dividing the pleural space into 
a left and a right hemithorax, separated by the media- 
stinum. A thin layer of glycoprotein-rich fluid sepa-
rates the pleura and allows the different intrathoracic 
structures to slide freely during respiration (Ettinger 
and Feldman, 2010). The pleural space of normal cats 
and dogs contains 0.1 and 0.3 mL/kg of fluid respec-
tively (Epstein, 2014). The production and absorption 
of this fluid represent a continuous process controlled 
by Starling’s forces. Hydrostatic pressure forces fluid 
out of the vasculature, while oncotic pressure main-
tains fluid within the vasculature. Any process that 
disrupts capillary or interstitial hydrostatic or oncotic 
pressures, lymphatic drainage or vessel integrity may 
result in fluid accumulation (Ettinger and Feldman, 
2010). The presence of 30 mL/kg of pleural effusion 
is assumed to cause mild breathing discomfort, while 
volumes up to 60 mL/kg result in severe dyspnea 
(Beatty and Barrs, 2010).
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Pathogenesis and bacteria associated with feline 
and canine pyothorax
Bacteria may enter the pleural space through com-
promised lung parenchyma, bronchi, esophagus or 
thoracic wall (Light, 2001; MacPhail, 2007). When 
the pleural space is faced with an infectious organ-
ism, it responds with edema and exudation of fluid, 
proteins and neutrophils into the pleural space. Meso- 
thelial cells then act as phagocytes and trigger an in-
flammatory response. This results in the release of 
chemokines, cytokines, oxidants and proteases. The 
rapidity and extent of progression depend on the type 
and virulence of the organism, the patient’s host de-
fences and the timing and effectiveness of antibiotic 
treatment. If initial effusion remains untreated, fibro-
purulent effusions or complex parapneumonic effu-
sions develop. Fibrin is formed in the pleural fluid 
and results in the formation of adhesions and locula-
tions. A complex parapneumonic effusion progresses 
to pyothorax when the concentration of leukocytes 
becomes sufficient to form pus, consisting of fibrin, 
cellular debris and viable or dead bacteria. If untreat-
ed, eventually, an organizing phase occurs with the in-
flux of fibroblasts and the formation of dense fibrous 
adhesions (Light, 2001; Sevilla et al., 2009; Christie, 
2010).
In general, it can be stated that bacteria isolated 
from canine and feline pyothorax are largely the 
same and most commonly consist of gram-negative, 
facultative anaerobic rods and/or obligate anaerobic 
bacteria, representing oropharyngeal flora (Walker et 
al., 2000; Demetriou et al., 2002). An important dif-
ference between both is the fact that isolated gram-
negative, facultative anaerobic rods are predominant-
ly non-enteric in origin in cats, e.g. Pasteurella spp., 
Pseudomonas spp., Actinobacillus spp., while they are 
mostly of enteric origin in dogs, e.g. Escherichia spp., 
Enterobacter spp., Klebsiella spp. (Love et al., 1982; 
Walker et al., 2000). A common mechanism of infec-
tion is the aspiration of oropharyngeal flora and the 
subsequent colonization of the lower respiratory tract 
(Piek and Robben, 2000; Barrs et al., 2005; MacPhail, 
2007; Barrs and Beatty, 2009a). Oropharyngeal flora 
may also gain access to the pleural space by aspira-
tion during dental procedures, migrating foreign bod-
ies, e.g. grass awns, penetrating thoracic wounds, e.g. 
bite wounds, stick injury, hematogenous spread from 
a distant wound or extension from underlying pulmo-
nary infection (Piek and Robben, 2000; Demetriou 
et al., 2002; Rooney and Monnet, 2002; Barrs et al., 
2005; Doyle et al., 2005; Johnson and Martin, 2007; 
MacPhail, 2007; Barrs and Beatty, 2009a). 
About 20% of feline pyothorax cases are caused 
by infectious agents other than oropharyngeal flora, 
including Rhodococcus equi, Nocardia spp., Kleb- 
siella spp., Proteus spp. and Pseudomonas spp. 
(Walker et al., 2000; Demetriou et al., 2002; Barrs and 
Beatty, 2009a). There is no clear data available con-
cerning the prevalence of pyothorax caused by non-
oropharyngeal flora in dogs.
Further, it should be mentioned that filamentous 
bacteria, e.g. Nocardia spp., Actinomyces spp., seem 
to be isolated from pyothorax more often in dogs than 
in cats (Walker et al., 2000; Sivacolundhu et al., 2001; 
Demetriou et al., 2002; Barrs et al., 2005). Isolation 
of Nocardia spp. has been reported in 12.5% of fe-
line cases, while it was found in 19% of canine cases 
(Demetriou et al., 2002). Actinomyces spp. are iden-
tified in the pleural fluid of 10 to 15% of cats with 
pyothorax but are present in up to 49% of dogs with 
pyothorax, although Actinomyces spp. form part of 
the normal oropharyngeal flora in both species. The 
higher prevalence of Actinomyces spp. in canine pyo-
thorax than in feline pyothorax might be explained by 
its association with grass awn migration in dogs (Si-
vacolundhu et al., 2001; Rooney and Monnet, 2002; 
Waddel et al., 2002; Barrs et al., 2005; Doyle et al., 
2009). 
Clinical signs and findings on physical examina-
tion 
The duration of clinical signs prior to diagnosis is 
typically one to two weeks, but it may take months 
(Barrs and Beatty, 2009a). In dogs, the disease is 
thought to be chronic at the time of presentation, be-
cause of its insidious nature and vague clinical signs 
(Rooney and Monnet, 2002). Cats are usually present-
ed even later, and by the time clinical signs of respira-
tory compromise become obvious, minimal respira-
tory reserve remains (Barrs and Beatty, 2009a). 
Both in cats and in dogs, clinical signs include 
partial or complete anorexia and lethargy or weakness 
in 80% of cases, followed by dyspnea and/or tachy-
pnea (Demetriou et al., 2002; Mellanby et al., 2002; 
Rooney and Monnet, 2002; Waddel et al., 2002; Barrs 
et al., 2005; Doyle et al., 2009; Boothe et al., 2010). 
The dyspnea of feline patients with pyothorax may 
be surprisingly subtle and is not noticed by 40% of 
the owners (Barrs et al., 2005). It is widely accepted 
that pleural effusion causes a restrictive pattern of res-
piration, characterized by an increase in respiratory 
rate and effort (MacPhail, 2007; Murphy and Papa-
souliotis, 2011a; Sigrist et al., 2011; Firth and Boag, 
2012). However, a large study investigating breathing 
patterns of different causes of dyspnea, revealed that 
pleural space disease is typically associated with ei-
ther an asynchronous (inspiration with inward move-
ment of the abdominal wall combined with outward 
movement of the thoracic wall) or an inverse (in-
spiration with outward movement of the abdominal 
wall combined with inward movement of the thorax) 
breathing pattern (Sigrist et al., 2011). Cats typically 
adopt a crouched, sternally recumbent posture with 
abducted elbows and often show open-mouth breath-
ing (Beatty and Barrs, 2010). 
Pyrexia and/or exercise intolerance have been 
reported in almost half of canine cases, while only 
28.6% of cats are presented with fever and hardly any 
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Table 1. Classification of pleural fluid based on total protein (TP) concentration, total nucleated cell count (TNCC) and 
cytology (Light, 2001; Beatty and Barrs, 2010; Ettinger and Feldman, 2010; Murphy and Papasouliotis, 2011a; Nelson 
and Couto, 2014; Zoia and Drigo, 2015).
 TP (g/L) TNCC (/µL) Cytology Common causes
Transudate < 25 < 1 500 Macrophages, mesothelial cells, Decreased oncotic pressure
   lymphocytes and non-degenerative (e.g. liver disease, protein losing
   neutrophils nefropathy, protein losing enteropathy),
    mildly increased hydrostatic pressure
    (e.g. right-sided heart failure,
    pericardial disease)
Modified transudate 25 - 75 1 000 – 7 000 Macrophages, mesothelial cells, Increased hydrostatic pressure
   lymphocytes and nondegenerative (e.g. right-sided heart failure,
   neutrophils pericardial disease), chronic lymphatic
    obstruction (e.g. neoplasia,
    diaphragmatic herniation)
Exudate > 30 > 7 000  Increased vascular permeability
(1) Nonseptic   1. Nondegenerative neutrophils,  1. Feline infectious peritonitis (FIP), 
   eosinophils, lymphocytes and neoplasia, lung lobe torsion
   macrophages
(2) Septic   2. Degenerative neutrophils, 2. Bacterial pneumonia, penetrating
   intracellular/extracellular bacteria thoracic or esophageal wounds, 
   and macrophages migrating foreign bodies 
 
Chylous effusion > 25 < 10 000 Small lymphocytes, nondegenerative  Leakage from thoracic duct 
   neutrophils and macrophages (e.g. neoplasia, idiopathic, congenital,
    traumatic, pericardial disease,
    cardiac disease, dirofilariosis,
    lung lobe torsion)
Hemorrhagic effusion > 30 < 10 000 Similar to peripheral blood Hemorrhage (e.g. trauma, coagulopathy,
    neoplasia, lung lobe torsion)
Neoplastic effusion > 25 Variable Inflammatory and reactive mesothelial Neoplasia of intrathoracical structures
   cells, neutrophils, macrophages and (e.g. mediastinal lymfoma,
   possibly neoplastic cells  pulmonary carcinoma)
cat shows signs of exercise intolerance (Demetriou et 
al., 2002; Boothe et al., 2010). Because cats are most-
ly presented in a very late stage of disease, they are of-
ten in a poor body condition (Demetriou et al., 2002; 
Waddel et al., 2002; Barrs et al., 2005). Coughing has 
been reported in 14% to 30% of feline cases and up to 
15% of cats with pyothorax have concurrent clinical 
signs of upper respiratory tract infection (oculonasal 
discharge and/or third eyelid prolapse) (Barrs et al., 
2005). Pyothorax is the most common cause of sep-
sis in cats, and hypothermia, present in 15% of feline 
cases, should alert for sepsis, particularly when ac-
companied by bradycardia (Brady et al., 2000; Barrs 
and Beatty, 2009a). Nevertheless, the absence of bra-
dycardia does not rule out sepsis or pyothorax, since 
in a study of Barrs et al. (2005), 20% of the cats had 
tachycardia, whereas bradycardia was not observed. 
Other clinical presentations occurring in a number of 
individual cats and dogs are submandibular abscess-
es, halitosis, cyanosis, lameness and pneumothorax 
(Demetriou et al., 2002).
On thoracic auscultation, respiratory sounds are 
decreased to absent. This is more pronounced ven-
trally and may be asymmetrical (Beatty and Barrs, 
2010; Murphy and Papasouliotis, 2011a; Sigrist et al., 
2011). Based on auscultation, the initial thoracocente-
sis should be performed on the side that is most affect-
ed (Beatty and Barrs, 2010). Pleural effusion may also 
create muffled heart sounds (Beatty and Barrs, 2010; 
Murphy and Papasouliotis, 2011a). The combination 
of auscultation along with percussion may be help-
ful in the diagnostic work-up of pleural space disease. 
On percussion, the presence of free fluid results in a 
low-pitched resonance (Murphy and Papasouliotis, 
2011a).
DIAGNOSIS
The diagnostic approach of pyothorax is based 
on the clinical signs, thoracocentesis, the evaluation 
of the effusion and thoracic radiographs (MacPhail, 
2007; Beatty and Barrs, 2010; Murphy and Papasou-
liotis, 2011a). Other medical imaging studies, such 
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as ultrasound (US) and computed tomography (CT), 
may be necessary to search for underlying causes. 
Complete blood count (CBC), serum biochemistry 
and urinalysis should form part of the minimum da-
tabase to assess the general clinical condition of the 
patient and to guide the management. However, they 
are not crucial for the diagnosis itself (Beatty and 
Barrs, 2010). Cats should always be tested for feline 
immunodeficiency virus (FIV) and feline leukemia 
virus (FeLV) (Waddell et al., 2002; Malik et al., 2006; 
Barrs and Beatty, 2009a).
Pleural fluid evaluation
The examination of pleural fluid is fundamental 
in the diagnostic work-up of animals with pleural 
space disease. Pleural effusion is classically divided 
in different categories based on protein content, to-
tal nucleated cell count (TNCC) and appearance on 
cytology (Ettinger and Feldman, 2010; Nelson and 
Couto, 2014) (Table 1). However, in one study, it has 
been suggested that Light’s classification of pleural 
fluid in human medicine would be superior in cats 
as well. This classification is based on lactate dehy-
drogenase concentration in the pleural fluid, pleural 
fluid/serum lactate dehydrogenase ratio and pleural 
fluid/serum total protein ratio and is thought to clas-
sify transudate, modified transudate and exudate more 
accurately than the classical categorization, but fur-
ther studies are needed (Zoia and Drigo, 2015). Aero-
bic and anaerobic culture should always be included 
(Love et al., 1982; Beatty and Barrs, 2010; Murphy en 
Papasouliotis, 2011a). The fluid should be collected 
in ethylene diamine tetra-acetic (EDTA) tubes for cell 
count and cytology, while a sterile container should be 
used for culture. For reliable anaerobic culture results, 
oxygen must be excluded from the transport specimen 
(Demetriou et al., 2002; Barrs and Beatty, 2009a). 
In some cases, macroscopic evaluation may give a 
first indication towards the type of effusion (Figure 2). 
The purulent exudate in pyothorax is associated with 
a malodorous smell in up to 80% of cases (Piek and 
Robben, 2000; Waddel et al., 2002; Barrs et al., 2005; 
Barrs and Beatty, 2009a). The fluid is usually opaque 
and creamy, but it can also be pink, green tinged or 
serohemorrhagic. Flocculent particles are often pres-
ent (MacPhail, 2007; Beatty and Barrs, 2010; Murphy 
and Papasouliotis, 2011a). 
Cytological examination generally shows a large 
population of predominantly degenerate neutrophils, 
polymorphic inflammatory cells, a small proportion 
of mononuclear cells and large numbers of pleio-
morphic, intracellular and/or extracellular bacteria 
(Demetriou et al., 2002; Barrs et al., 2005; MacPhail, 
2007; Ettinger and Feldman, 2010). The macrophages 
demonstrate phagocytosis of debris and bacteria. In 
general, most cases of pyothorax are characterized 
by a polymicrobial infection on cytology (Waddell et 
al., 2000; Demetriou et al., 2002; Rooney and Mon-
net, 2002; Barrs et al., 2005; Klainbart et al., 2007). 
In one case series in 27 cats, 7% showed no bacteria 
on cytology, while 78% were presented with a poly-
microbial infection and 15% showed a single type of 
bacterium (Barrs et al., 2005). In another case series 
in 14 cats and 36 dogs, no bacteria were seen in 20% 
of cases, 37.5% showed a polymicrobial infection and 
42.5% was characterized by a single type of bacte-
rium (Demetriou et al., 2002). Some bacteria, such as 
Nocardia spp. and Actinomyces spp., have a filamen-
tous shape and acid-fast stains may aid in their differ-
entiation (Demetriou et al., 2002; Malik et al., 2006; 
Doyle et al., 2009). 
Figure 2. Macroscopic appearance of different types of effusion. A. Transudate secondary to protein losing enteropathy. 
B. Modified transudate caused by right-sided heart failure. C. Non-septic exudate caused by feline infectious peritonitis 
(FIP). D. Septic exudate from pyothorax. E. Hemothorax caused by mediastinal lymphoma. F. Idiopathic chylothorax.
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Infectious agents may not always be present cy-
tologically due to prior antimicrobial therapy. The 
cytological results should therefore always be com-
pared to the culture results (Barrs and Beatty, 2009a). 
Unfortunately, culture of pleural fluid may be false 
negative due to prior antibiotic therapy or insufficient 
growth of certain isolates in vitro. Positive bacterial 
cultures of pleural fluid have been reported in 68.7% 
of canine and feline cases with pyothorax (Demetriou 
et al., 2002). However, in other studies, a positive cul-
ture in less than half of the examined dogs has been 
reported (Johnson and Martin, 2007), whereas 78% of 
cats have a positive culture (Barrs et al., 2005). Low 
canine positive culture results may be explained by 
prior antibiotic therapy or by losing strictly anaerobic 
bacteria prior to culture, as a result of air contamina-
tion during sample collection and transport (Love et 
al., 1982; Piek and Robben, 2000; Johnson and Mar-
tin, 2007). 
Complete blood count (CBC) and serum biochem-
istry
Complete blood count (CBC) generally shows a 
neutrophilic leukocytosis with a left shift, i.e. an in-
creased concentration of nonsegmented or band neu-
trophils, as expected for pyogenic infections, but a de-
generative left shift or leukopenia may be indicative 
for sepsis (Brady et al., 2000; Demetriou et al., 2002; 
Waddel et al., 2002; Barrs et al., 2005; Klainbart et 
al., 2007). A mild to moderate anemia is seen in up 
to 20% of feline and canine cases (Brady et al., 2000; 
Demetriou et al., 2002; Barrs and Beatty, 2009a). In 
86% of feline cases with anemia, the anemia is non-
regenerative and mostly normocytic and normochro-
mic (Ottenjann et al., 2006). 
The most common abnormalities on serum bio-
chemistry are hypoalbuminemia, hyperbilirubinemia, 
hyponatremia, hypochloremia and mild elevations of 
aspartate aminotransferase (AST) (Barrs et al., 2005; 
Klainbart et al., 2007; MacPhail, 2007; Barrs and 
Beatty, 2009a). Hypoalbuminemia and hyperbilirubi-
nemia are both common findings in sepsis (Brady et 
al., 2000). The decrease in albumin may be caused 
by increased vascular permeability, decreased hepatic 
synthesis and loss of protein in the pleural fluid in se-
vere acute infections (Waddel et al., 2002; Barrs et 
al., 2005; Barrs and Beatty, 2009a). Hyponatremia 
and hypochloremia may be explained by decreased 
intake due to anorexia or may be attributed to the loss 
of fluid into the thoracic cavity. AST is commonly 
increased due to hepatocellular or myocyte damage. 
Possible mechanisms include hypoxia-induced dam-
age secondary to poor perfusion due to hypovolemia 
or sepsis, inflammation from concurrent processes, 
e.g. pancreatitis, and infection within the liver caused 
by hepatic abscesses (Waddel et al., 2002). 
Medical imaging
The importance of gentle handling of animals in 
respiratory distress cannot be overemphasized. Some 
procedures, such as medical imaging, may need to 
wait until the patient is stable enough, e.g. after tho-
racocentesis. Severe hypoxemia may occur if the ani-
mal is placed in lateral or dorsal recumbency. Reduc-
ing oxygen requirements and stress through minimal 
handling or fixation, combined with anxiolytic drugs 
and/or sedation and supplementation of oxygen are 
the first steps in stabilization to obtain better respira-
tory comfort (Beatty and Barrs, 2010). 
A B
Figure 3A. Right lateral and dorsoventral thoracic radiographs of a cat with severe pyothorax. B. The radiographs 
were taken after left-sided thoracocentesis, through which 180 mL of yellow, opaque fluid had already been removed. 
The lung lobes are retracted from the thoracic wall by a soft tissue opacity in both left and right hemithorax. The 
effusion is asymmetrical, showing more severe effusion in the right hemithorax, which might be a consequence of 
previous left-sided thoracocentesis. There is scalloping of the ventral lung lobes.
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Radiography (RX)
A single dorsoventral projection confirms the pres-
ence of pleural effusion (Beatty and Barrs, 2010), 
while a lateral projection helps to detect loculations 
(Christie, 2010). If the volume of effusion is small and 
more information is desired, other projections may be 
indicated. A ventrodorsal radiograph is more sensitive 
for the detection of small-volume effusions. However, 
there is a considerable risk of serious respiratory com-
promise if a patient has a moderate- to large-volume 
effusion. Therefore, this projection is not routinely 
advised (Murphy and Papasouliotis, 2011a). To assess 
if there is any underlying bronchopulmonary disease 
present, a complete set of thoracic radiographs should 
be obtained after pleural fluid removal, because they 
may have been effaced by fluid or obscured by atelec- 
tasis (Barrs and Beatty, 2009a; Beatty and Barrs, 2010; 
Epstein, 2014). It can take some time for the lungs to 
re-expand fully; hence, taking radiographs immedi-
ately after fluid removal may not be ideal (Murphy 
and Papasouliotis, 2011a).
Radiographically, a small volume of pleural ef-
fusion is characterized by the presence of interlobar 
fissure lines, though this may also be caused by pleu-
ral thickening (Murphy and Papasouliotis, 2011a). In 
cases with moderate to large amounts of free fluid, 
the retraction of the lobar borders from the thoracic 
wall, resulting in rounded lung borders, is particularly 
obvious in the caudodorsal areas of the lung. Other 
signs include lung collapse due to incomplete expan-
sion, dorsal displacement of the trachea, widening of 
the mediastinum, obscuring of the cardiac silhouette 
and diaphragm, and scalloping of the lung margins at 
the sternal border (Barrs and Beatty, 2009a; Beatty 
and Barrs, 2010; Murphy and Papasouliotis, 2011a) 
(Figures 3A and B). 
In dogs and cats, communication between the left 
and the right hemithorax may vary individually and 
can be influenced by concurring disease (Epstein, 
2014). In a case study of 76 cats, a bilateral pleural ef-
fusion in 76%, a unilateral left-sided pleural effusion 
in 16% and a unilateral right-sided pleural effusion 
in 8% were reported (Barrs et al., 2005). The pres-
ence of unilateral effusion on radiographs should in 
any case raise the index of suspicion for pyothorax (or 
chylothorax) (Beatty and Barrs, 2010). Overall, cats 
with pyothorax have a higher frequency of unilateral 
effusion with up to 29% of cases, compared to 14% of 
cases in dogs with pyothorax (Demetriou et al., 2002; 
Barrs et al., 2005). 
Ultrasonography (US)
Although thoracic radiography is more sensitive 
than ultrasonography in detecting small-volume pleu-
ral effusions, thoracic ultrasonography is a less inva-
sive technique for the confirmation of a moderate to 
large volume of pleural effusion (Beatty and Barrs, 
2010). Thoracic ultrasonography may also be indicated 
to identify consolidated lung masses, mediastinal 
masses and abscedated or neoplastic lung nodules. It 
can also be used for guided thoracocentesis when only 
a small amount of pleural fluid is present (MacPhail, 
2007). The exudate in pyothorax is hypoechoic or 
complex echoic (Beatty and Barrs, 2010). 
Computed tomography (CT)
With a computed tomography (CT) scan, the se-
verity and the location of the pleural effusion can be 
determined and a detailed assessment of underlying 
parenchymal and pleural abnormalities can be pro-
vided (Swinbourne et al., 2011). In cases of migra- 
ting intrathoracic grass awns in dogs, CT has been re-
ported to detect more sites of abnormalities and traces 
the foreign body pathway more accurately than ra-
diographs (Swimbourne et al., 2011; Jiménez Peláez 
and Jolliffe, 2012; Vansteenkiste et al., 2014). Cur-
rently, CT is mostly used after patient stabilization to 
determine whether surgical intervention is indicated 
(MacPhail, 2007; Swimbourne et al., 2011). In con-
trast to what is mostly assumed, CT does not neces-
sarily require general anesthesia and could therefore 
be used in more critical phases of diagnosis as well. 
While dogs require at least a deep sedation, cats tend 
to be fixated very well in a transparent container, e.g. 
VetMouseTrap, which allows quick and safe scanning 
without sedation (Oliveira et al., 2011; Schwarz and 
O’Brien, 2011).
TREATMENT
In some studies, death has been reported during 
clinical examination or shortly after (Mellanby et al., 
2002; Barrs et al., 2005), highlighting the importance 
of minimal, careful handling and immediate supple-
mentary oxygen (Barrs and Beatty, 2009b). The emer-
gency patient should receive immediate intravenous 
fluid therapy if indicated. Afterwards, the level of 
pain should be assessed. Pleuritis and thoracic vis-
ceral pain are associated with a moderate to severe 
level of pain and a multimodal approach is advised 
(Lemke and Dawson, 2000; Mathews et al., 2014). In 
many cases, opioids are the initial drug of choice, e.g. 
buprenorphine; 0.01-0.02 mg/kg IV tid-qid. However, 
caution should be taken in patients with respiratory 
distress (Mathews et al., 2014). After stabilization, 
non-steroidal anti-inflammatory drugs, e.g. meloxi-
cam; 0.1 mg/kg IV sid in dogs and 0.05 mg/kg SC in 
cats, can be added if there are no contraindications. 
Additionally, a CRI of ketamine, e.g. bolus of 0.5-1 
mg/kg and CRI at 0.12-0.6 mg/kg/h in dogs; bolus of 
0.5 mg/kg and CRI at 0.3-1.2 mg/kg/h in cats, may 
help in controlling severe pain (Mathews et al., 2014). 
If persisting thoracic visceral pain is suspected, the 
use of intrapleural blocks can be considered (Lemke 
and Dawson, 2000; Mathews et al., 2014). Treatment 
with systemic antibiotics alone usually does not over-
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come the infection and removal of the exudate will 
be necessary (Piek and Robben, 2000). This drainage 
can take place through single or multiple thoraco-
centeses or though placement of thoracostomy tubes, 
with or without lavage of the pleural cavity (Piek and 
Robben, 2000; Demetriou et al., 2002; Rooney and 
Monnet, 2002; Boothe et al., 2010). In patients that 
are medically managed for two to three days without 
improvement, surgery should be considered (Monnet, 
2009).
Antimicrobial therapy
Initial antimicrobial therapy is based on the cyto- 
logyof the pleural fluid. Single antimicrobial thera-
py in dogs has a 35%-risk of inefficacy. Therefore, 
a combined antimicrobial treatment seems prudent 
(Demetriou et al., 2002; Barrs and Beatty, 2009b; 
Boothe et al., 2010). A gram-stain of the fluid sample 
should be made and may help the clinician in choos-
ing an appropriate antimicrobial agent for initial treat-
ment (Love et al., 1982; Murphy and Papasouliotis, 
2011b). Therapy should be altered afterwards, based 
on the results of culture and susceptibility testing 
(Walker et al., 2000; Klainbart et al., 2007; Barrs and 
Beatty, 2009b; Murphy and Papasouliotis, 2011b). 
Initial antibiotics should be administered parenterally, 
preferably intravenously. Once the patient is eating 
well, oral antibiotics may be substituted (Barrs and 
Beatty, 2009b).
Given that the majority of cases is characterized 
by synergistic polymicrobial infections caused by 
oropharyngeal flora, antibiotics should ideally be ef-
fective against anaerobes as well as gram-positive and 
gram-negative aerobes (Walker et al., 2000; Barrs and 
Beatty, 2009b). Penicillins and their derivates, e.g. 
amoxicillin-clavulanic acid, 10-40 mg/kg bid or tid, 
are reliably effective against obligate anaerobes, such 
as Bacteroides spp., and are especially a good treat-
ment in cats, as enterobacteriaceae are not frequently 
isolated in the pleural fluid (Demetriou et al., 2002; 
Barrs et al., 2005; Barrs and Beatty, 2009b). Alterna-
tively, fluoroquinolones, e.g. enrofloxacine, 5-7 mg/
kg sid, or cephalosporins, e.g. cefazolin, 20-30 mg/kg 
tid, could be used as first-choice antibiotics (Deme-
triou et al., 2002; Greene, 2006; Barrs and Beatty, 
2009b). Monotherapy with pradofloxacin has a high 
activity against isolates of anaerobic bacteria in dogs 
as well as in cats, but should be used with care be-
cause of the increasing resistance in treating human 
anaerobic infections (Stein and Goldstein, 2006). A 
combination of β-lactam antibiotics with fluoroqui-
nolones for more than six weeks is advised to treat 
Actinomyces-infections (Sivacolundhu et al., 2001; 
Rooney and Monnet, 2002; MacPhail, 2007). Other 
antibiotics that can be used against Actinomyces spp. 
are clindamycin, chloramphenicol and gentamicin 
(Sivacolundhu et al., 2001; MacPhail, 2007; Barrs 
and Beatty, 2009b). 
Metronidazole (15-50 mg/kg bid) can be used be-
cause of its lipophilic qualities. It is well distributed 
throughout the body and diffuses well into abscess-
es (Johnson and Martin, 2007). It is mostly used in 
combination with other antibiotics, because it is only 
effective against anaerobic bacteria (Piek and Rob-
ben, 2000; Murphy and Papasouliotis, 2011b). In 
high dosages or when administered for a long period 
of time, which is often necessary in the treatment of 
pyothorax, neurological side effects such as general-
ized muscle weakness can be seen (Piek and Robben, 
2000).
Sulphonamides, e.g. trimethoprim-sulphamethoxa- 
zole (TMP-SDX), 5-10 mg/kg trimethoprim and 
25-50 mg/kg sulfamethoxazole sid, are effective for 
high percentages of Nocardia isolates (Peabody and 
Seabury, 1960; Yildiz and Doganay, 2006; MacPhail, 
2007; Malik et al., 2006; Sullivan and Chapman, 
2010; Murphy and Papasouliotis, 2011b). This dos-
age of TMP-SDX is often effective, but not always 
well tolerated, resulting in excessive salivation due to 
the bitter taste, vomiting and partial to complete an-
orexia. In cats, high dosages may induce anemia and 
neutropenia due to bone marrow suppression (Malik 
et al., 2006). In dogs, severe neurological signs, such 
as generalized muscle weakness, may occur (Piek and 
Robben, 2000). 
The appropriate duration of treatment in veterinary 
patients with pyothorax has not been well studied, but 
should be long-term, i.e. at least 4-6 weeks. In cases 
with isolation of filamentous organisms, treatment 
must be continued longer, since these infections are 
associated with devitalized tissue and tend to relapse if 
therapy is discontinued prematurely (Demetriou et al., 
2002; Barrs et al., 2005; Malik et al., 2006; MacPhail, 
2007). Treatment is necessary for a minimum of three 
months and can be prolonged for as long as one year 
in patients with disseminated disease (Sivacolundhu 
et al., 2001; Yildiz and Doganay, 2006).
Thoracic drainage
Needle thoracocentesis 
Thoracocentesis can be diagnostic as well as thera-
peutic (MacPhail, 2007). Single or repeated needle 
thoracocentesis can be performed prior to tube tho-
racostomy. The removal of as much of the fluid as 
possible gives considerable relief (Barrs and Beatty, 
2009b). Typically, a 20- or 22-gauge needle or but-
terfly catheter, connected to an extension tube with 
a three-way stop valve, is used. Using a sterile tech-
nique, the needle is advanced into the pleural cavity at 
the level of the ventral third of the thorax, mostly in 
the seventh or eighth intercostal space (ICS), cranial 
to the rib. Multiple thoracocenteses spread in time 
are generally not recommended and often ineffective 
(Barrs et al., 2005; MacPhail, 2007). However, one 
study performed by Johnson and Martin (2007) in 
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Figure 4. Placement and fixation of a thoracostomy tube in a dog. A. The eleventh intercostal space is localized. B. A skin 
incision is made in the dorsal third of the eleventh intercostal space. C. The skin is pulled cranially, bringing the skin 
incision at the level of the eighth intercostal space. D. The thoracic drain is inserted perpendicular to the thoracic wall. E. 
The thoracic drain is advanced in cranioventral direction. F. The skin is moved caudally. G. This results in subcutaneous 
tunnelling. H. The thoracic drain is attached to the skin using a purse-string suture and a Chinese finger trap. 
Note: These pictures were taken on a euthanized dog. Sterile preparation and surgical draping are required to provide a 
sterile working field, but were disguarded in this case.
Vlaams Diergeneeskundig Tijdschrift, 2017, 86 193
15 dogs without inhaled foreign body or pyogranu-
lomatous effusion, showed a successful treatment of 
pyothorax in all 15 dogs through single unilateral tho-
racocentesis along with long-term antibiotic therapy.
Thoracostomy tubes and thoracic lavage
If needle thoracocentesis fails to stabilize or man-
age the clinical signs, chest drain placement is rec-
ommended (Valtolina and Adamantos, 2009). It can 
also be used in therapeutic procedures such as pleural 
lavage or in surgical cases following a thoracotomy 
(Murphy and Papasouliotis, 2011a). In complex cases 
with numerous pleural adhesions or in animals with 
a complete mediastinum, bilateral chest tubes are 
more likely to provide effective drainage than unila-
teral chest tubes (Barrs et al., 2005; Barrs and Beatty, 
2009b).
The placement of thoracostomy tubes is simple 
and is generally well tolerated. Sedation or anesthe-
sia may be necessary for uncooperative or stressed 
patients. The thoracostomy tube of the greatest dia-
meter that can fit comfortably in the intercostal space 
(ICS) should be used, since wider bore tubes facilitate 
drainage of pus (Rahman and Gleeson, 2006; Barrs 
and Beatty, 2009b). The placement of chest tubes is 
preferably done with the animal standing or in sternal 
position (Frendin and Obel, 1997; MacPhail, 2007; 
Barrs and Beatty, 2009b; Murphy and Papasouliotis, 
2011b). To minimize pneumothorax from leakage of 
air around the tube, subcutaneous tunneling of the 
drain should be achieved by entering the chest tube 
through the skin two or more ICS caudal to where the 
tube enters the thoracic cavity. After extensive clip-
ping, aseptic preparation and local anesthesia, a small 
skin incision is made in the dorsal third of the tenth to 
twelfth ICS, lateral to the longissimus dorsi muscle. 
The skin is pulled cranially and the tube is inserted in 
the chest perpendicular to the thoracic wall around the 
eighth ICS. Afterwards, the drain is moved in cranio-
ventral direction. The tube needs to be clamped or a 
three-way valve has to be placed to prevent iatrogenic 
pneumothorax (Frendin and Obel, 1997; Barrs and 
Beatty, 2009b). Thoracostomy tubes without stylets 
can be placed, using large hemostats to perforate the 
intercostal muscles. After placement, tubes should be 
secured to the thoracic wall by a purse-string suture 
and a Chinese-finger trap to prevent the tube from 
slipping (Figures 4A-H). Finally, a bandage is needed 
to prevent the animal from manipulating the tube. 
The bandage should be changed at least once daily 
(Barrs and Beatty, 2009b; Murphy and Papasouliotis, 
2011b). Control radiographs should be taken immedi-
ately after drain placement to assess its position. The 
tip of the drain should end in the ventral 2nd-3rd ICS 
to be positioned correctly (Barrs et al., 2005). 
Chest tubes can be drained continuously or in-
termittently, e.g. every 4 hours. Continuous suction 
offers the advantage of maximal drainage, but gives 
more severe complications if the system detaches, 
which would remain unrecognized. Intermittent suc-
tion is easier, less expensive, requires less monitor-
ing and is sufficient in most cases (Barrs and Beatty, 
2009b; Murphy and Papasouliotis, 2011b). Hygienic 
procedures should be respected when draining the 
tube to prevent infection. Analgesia is necessary and 
usually includes systemic opioids. Interpleural use of 
bupivacaine is controversial. Some authors state that 
interpleural analgesia should be avoided in patients 
with poor respiratory reserves because of the potential 
diaphragmatic paralysis (Kowalski et al., 1992; Barrs 
and Beatty, 2009b). In other reports, it is described 
that, when using the correct dosages, e.g. 1.5 mg/kg, it 
can provide sufficient analgesia for up to eight hours 
with minimal risks of cardiovascular or pulmonary 
side effects (Lemke and Dawson, 2000; Glowaski, 
2002). 
Drainage should ideally be combined with inter-
mittent thoracic lavage. This facilitates exudate drain-
age and prevents obstruction of the thoracostomy 
tubes by reducing pleural fluid viscosity. It also al-
lows hydraulic debridement of the pleura, including 
breakdown of adhesions and dilution of bacteria and 
inflammatory mediators (Barrs and Beatty, 2009b; 
Boothe et al., 2010). Thoracic lavage must be car-
ried out every four hours for the first two days. After-
wards, two to three times daily is usually adequate. As 
lavage solution, 0.9% sodium chloride or Hartmann’s 
solution (to prevent hypokalemia), heated to body 
temperature, can be safely used in volumes of 10-25 
mL/kg/lavage. Slow and hygienic infusion is neces-
sary, combined with close monitoring of the patient. 
Recovery of 75% or more of the lavage solution after 
30-60 minutes is expected, preferably after walking or 
moving the patient (Barrs and Beatty, 2009b; Boothe 
et al., 2010).
Complex loculated effusions or cases with ad-
vanced fibrinous or fibrous adhesions can be treated 
with subsequent administration of fibrinolytic agents 
through the tube (Rahman and Gleeson, 2006). Re-
ported side effects include fever and bleeding. Fi-
brinolytic agents that can be used are heparin (10-
15 IU/mL of lavage fluid), streptokinase, urokinase 
and tissue plasminogen activator (Demetriou et al., 
2002; Boothe et al., 2010; Christie, 2010). Scientific 
evidence in veterinary medicine is still scarce, but in 
one study, improvement of both short- and long-term 
survival in dogs that were lavaged with a heparin-con-
taining solution has been reported. No adverse effects 
were registered, but blood coagulation profiles were 
not monitored (Boothe et al., 2010). 
In one study of 98 dogs, up to 22% of dogs develo-
ped some type of complication after the placement 
of thoracostomy tubes (Tattersall and Welsh, 2006). 
This is especially important in cases of pyothorax 
(and chylothorax), given that the tubes usually stay 
in place longer than in cases of other pleural space 
diseases. Therefore, complications occur more often 
(Tattersall and Welsh, 2006). Described complica-
tions include pneumothorax, serohemorrhagic dis-
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charge from around the drain/skin interface, subcu-
taneous emphysema or edema, blockage of the drain 
with fibrin clots, infection of the thoracic wall with 
abscesses, lung tissue irritation or trauma, re-expan-
sion pulmonary edema, arrythmias, phrenic nerve ir-
ritation and hemorrhage from laceration of intercostal 
vessels (Tattersall and Welsh, 2006; Barrs and Beatty, 
2009b; Valtolina and Adamantos, 2009). In cats, the 
incidence of complications after thoracostomy tube 
placement is even higher, with a reported prevalence 
of 58% (Barrs et al., 2005). 
Constant monitoring to observe changes in respi-
ratory pattern and frequent clinical examination are 
advised. The volume of lavage solution administered 
and aspirated should be noted carefully and daily cy-
tology of the fluid is recommended to assess thera-
peutic response. Regular monitoring with thoracic 
radiographs, preferably every two or three days, is 
necessary to detect failure of drainage due to incorrect 
tube placement, tube kinking or adhesions (Barrs and 
Beatty, 2009b; Murphy and Papasouliotis, 2011b). 
Thoracostomy tubes are generally removed after four 
to six days, but the ideal time of removal should be 
evaluated individually. Factors indicating possible 
removal are the reduction of the pleural effusion to 
2-4 mL/kg/day, minimal amounts of remaining pleu-
ral effusion on thoracic radiographs and resolution 
of infection on cytology. Cytological examination of 
the pleural fluid should gradually contain less bacte-
ria and less neutrophils with decreasing degenerative 
appearance (Demetriou et al., 2002; Klainbart et al., 
2007; Barrs and Beatty, 2009b; Marques et al., 2009; 
Murphy and Papasouliotis, 2011b). 
Surgical approach
The advantage of surgical treatment lies in a thor-
ough exploration and removal of the primary cause 
with lavage and debridement of the pleural space. 
However, this must be weighed against the risks of 
general anesthesia in a compromised patient, the in-
creased costs and prolonged hospital stay (Doyle et 
al., 2005; MacPhail, 2007). Common indications for 
early surgical intervention are the detection of an 
underlying lesion, e.g. abscess, foreign body, exten-
sively loculated effusions or poor response to medi-
cal treatment after two to seven days (Rooney and 
Monnet, 2002; Barrs and Beatty, 2009b; Boothe et 
al., 2010). Surgery is also indicated when pneumo-
thorax or drain obstruction caused by pleural adhe-
sions, develops (Barrs and Beatty, 2009b). In dogs, 
a surgical approach is recommended if Actinomyces 
spp. is isolated, because of the poor outcome asso-
ciated with medical therapy only, given the frequent 
association with migrating grass awns (Rooney and 
Monnet, 2002; Doyle et al., 2009). In cats however, 
the medical treatment of pyothorax caused by Actino-
myces spp. (in combination with other oropharyngeal 
flora) is often sufficient, because it is less likely to be 
associated with grass awn foreign bodies (Barrs and 
Beatty, 2009b).
Intercostal thoracotomy or median sternotomy 
Because surgical treatment of pyothorax usually 
requires exposure and exploration of both hemitho-
races, median sternotomy is the most common sur-
gical approach. It is used when preoperative workup 
reveals generalized disease or when no clear underly-
ing cause can be found (Tattersall and Welsh, 2006; 
MacPhail, 2007; Boothe et al., 2010). Intercostal 
thoracotomy is not commonly used for exploratory 
purposes, but it may be a good approach when preop-
erative diagnostics reveal a focal lesion in a specific 
region (Tattersall and Welsh, 2006). It also enables 
more accurate positioning of thoracostomy tubes than 
median sternotomy (MacPhail, 2007; Barrs and Be-
atty, 2009b; Crawford et al., 2011). Affected lung tis-
sue can be removed by pneumectomy. Acute loss of 
up to 50% of lung tissue is followed by compensa-
tory changes in the contralateral lung. The removal 
of the entire right or left lung is usually well tolerated 
in cats. However, in dogs, right-sided pneumectomy 
is not well tolerated, because the right lung accounts 
for 58% of all lung tissue. Samples for bacteriology 
and, if indicated, histology must be taken during the 
surgical procedure. Postoperative oxygen supplemen-
tation, analgesia, careful monitoring and management 
of chest drainage are essential for successful recovery 
(Crawford et al., 2011). 
Thoracoscopy
Video-assisted thoracoscopic surgery (VATS) is a 
recent diagnostic and therapeutic tool, which provides 
minimal invasive access to the thoracic cavity. It al-
lows exploration of the entire pleural space, biopsies 
and culture samples, and debridement of the media-
stinum and other tissues involved in the infectious 
process (Kovak et al., 2002; MacPhail, 2007; Monnet, 
2009; Jiménez Peláez and Jolliffe, 2012). The disad-
vantages include the need for specific instrumentation 
and possible technical difficulties. Although there is 
little scientific evidence in veterinary medicine, thora-
coscopy seems to be a safe and effective procedure in 
dogs and cats with rapid patient recovery, high success 
rates with shorter duration of chest tube drainage, less 
postoperative pain and shorter hospital stay than more 
invasive surgery (Christie, 2010; Jiménez Peláez and 
Jolliffe, 2012). If thoracoscopic exploration reveals 
multiple adhesions with severe involvement of lung 
lobes or pericardium, the conversion from thoraco-
scopy to sternotomy is advised (Monnet, 2009). 
PROGNOSIS
The prognosis in cats and dogs with pyothorax is 
variable, ranging from excellent to extremely guard-
ed, often resulting in death or euthanasia (Murphy and 
Papasouliotis, 2011a). The underlying cause, the ex-
tent of the disease and the rate of progression have an 
influence on both clinical signs and prognosis. Medi-
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cal treatment fails in up to one third of all patients 
with pyothorax, but guidelines to when surgical in-
tervention should be performed remain unclear and 
surgery is often disguarded due to financial concerns 
(Waddell et al., 2002; Rahman and Gleeson, 2006; 
MacPhail, 2007; Boothe et al., 2010). 
One of the most common complications of pyo-
thorax is recurrence (Demetriou et al., 2002; Waddell 
et al., 2002; Barrs et al., 2005). Recurrence rates are 
usually low, but vary greatly according to the type of 
treatment and the underlying cause (Demetriou et al., 
2002; Rooney and Monnet, 2002; Waddell et al, 2002; 
Boothe et al., 2010). Cases involving Nocardia spp. 
or Actinomyces spp. tend to relapse most frequently, 
especially when treated without surgery, because they 
are often associated with complex pyogranulomatous 
disease (Peabody et al., 1960; Sivacolundhu et al., 
2001; Malik et al., 2006; Doyle et al., 2009). 
In cats, 50-100% of the non-survivors die or are 
euthanized within the first 48 hours after presentation. 
It is therefore considered that survival of the first 48 
hours can serve as a good prognostic indicator (Deme-
triou et al., 2002; Waddell et al., 2002). Survival rates 
vary greatly according to the type of treatment. In 
one study of 80 cats, 66% of the cats survived, each 
of them receiving an appropriate type of treatment 
(Waddell et al., 2002). In 19 cats treated with intrave-
nous fluids combined with antimicrobial therapy and 
drainage through thoracostomy tubes, a 95% success 
rate has been reported (Barrs et al., 2005). In contrast, 
mortality rates as high as 80% have been reported in 
cats when drainage was achieved through single or 
multiple thoracocenteses, without placement of chest 
tubes (Bauer, 1986). On average, cats that have under-
gone surgery, are generally hospitalized for six days 
prior to surgical intervention. They have higher sur-
vival rates than cats that have been treated more con-
servatively, probably due to more effective drainage 
postoperatively (Waddel et al., 2002). The available 
data in cats shows a recurrence rate between 5 and 8% 
in general, but it could increase up to 23% in cases of 
pyothorax caused by Nocardia infections (Demetriou 
et al., 2002; Waddell et al., 2002; Barrs et al., 2005; 
Malik et al., 2006).
In dogs, a good outcome is often seen when therapy 
includes intravenous antibiotic therapy and drainage 
of the pleural fluid, with or without the placement 
of thoracostomy tubes and lavage (Piek and Rob-
ben, 2000; Demetriou et al., 2002; Johnson and 
Martin, 2007). It should be noted that in these cases, 
foreign bodies or filamentous bacteria are usually not 
included (Piek and Robben, 2000; Demetriou et al., 
2002; Johnson and Martin, 2007). Short-term survival 
rates of dogs undergoing surgical therapy are thought 
to be about five times higher than dogs treated con-
servatively (MacPhail, 2007; Boothe et al., 2010). 
Survival rates vary between 29 and 100% for medical 
treatment and up to 92% for surgical treatment (Mel-
lanby et al., 2002; Rooney and Monnet, 2002; Boothe 
et al., 2010;  Lee, 2014). 
DISCUSSION
Pyothorax is an uncommon disease in dogs and 
cats, but can potentially be life-threatening. At the 
moment, there is no data available concerning the ac-
tual incidence of pyothorax in dogs and cats, but it 
appears to occur more frequently in cats (Demetriou 
et al., 2002; Rooney and Monnet, 2002; Barrs et al., 
2005; MacPhail, 2007; Boothe et al., 2010). An im-
mediate and appropriate diagnostic and therapeutic 
approach is essential to obtain a good outcome (Barrs 
and Beatty, 2009b; Firth and Boag, 2012). The time 
between the occurrence of the clinical signs and the 
start of therapy are of great importance. Treatment 
should minimally consist of careful handling, sup-
portive care, antibiotic treatment and drainage of the 
pleural fluid (Rooney and Monnet, 2002; Barrs et al., 
2005; Boothe et al., 2010). It is recommended to place 
bilateral thoracostomy tubes in all bilateral cases of 
pyothorax, although there is no clear concensus in 
the literature as to whether bilateral drainage is su-
perior to unilateral drainage. In cases with multiple 
loculations of fluid, however, bilateral thoracostomy 
tubes seem to be necessary for adequate drainage of 
the pleural fluid (Demetriou et al., 2002; Barrs and 
Beatty, 2009b; Boothe et al., 2010; Christie 2010; Ep-
stein, 2014; Lee, 2014). 
Careful clinical and radiographic monitoring is 
important to assess therapeutic response. There is no 
clear data available as to whether or not surgery is in-
dicated. However, it should be considered when there 
is poor reponse to medical therapy, in the presence 
of structural lesions or pneumothorax and in cases 
where involvement of filamentous organisms is sus-
pected (Doyle et al., 2009; Murphy and Papasouliotis, 
2011b). Thoracoscopy seems to be a very promising 
technique that can be used both diagnostically and 
therapeutically (Kovak et al., 2002; MacPhail, 2007). 
In some cases, with thoracoscopy, the cause of pyo-
thorax can be resolved, but conversion to thoracotomy 
or sternotomy may still be necessary (Monnet, 2009). 
A good first choice of antibiotic therapy consists of 
amoxicillin-clavulanic acid (10-40 mg/kg bid or tid) 
in cats and a combination of amoxicilline (20-40 mg/
kg bid or tid) and enrofloxacine (5 mg/kg sid) should 
be considered in dogs, based on the susceptibility of 
the most commonly isolated organisms in both spe-
cies (Greene, 2006). It should be emphasized that the 
appropriate antibiotic therapy should always be al-
tered according to the results of cytology and gram-
stain, and if necessary, changed again according to the 
results of the bacteriological examination and suscep-
tibility testing. 
The optimal duration of antibiotic therapy in cases 
of pyothorax still needs to be elucidated. A sufficient 
duration of treatment may prevent recurrence of in-
fection, which is a common and serious complication. 
Finally, veterinarians must take effort in preventing 
pyothorax by adequately treating bite wounds and lo-
cal infections. Given that oropharyngeal bacteria are 
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the most common source of infection of the pleural 
space, it is recommended that cats undergoing dental 
surgery, cats suffering from upper respiratory tract in-
fections and cats that have been involved in a catfight 
should be treated with antibiotics as a prophylactic 
measure (Barrs et al., 2005; Barrs and Beatty, 2009b). 
Whether this will actually reduce the incidence of 
pyothorax still needs to be investigated, and the po-
tential benefits must be weighed against the risk of 
increasing antimicrobial resistance.
CONCLUSION
Pyothorax is thought to be an uncommon disease, 
but there is few data available regarding incidence, 
and most common underlying causes are yet to be fur-
ther investigated. Treatment should always consist of 
supportive care, long-term antibiotics and drainage of 
the effusion, but it should be emphasized that there 
is no golden standard, and treatment approach should 
always be evaluated individually. Although the re-
sults of one canine study were promising, the addi-
tion of thoracic lavage is yet to be studied, as there 
is no clear scientific advice regarding the amount, 
the frequency and/or the type of lavage. In addition, 
further research regarding possible complications is 
indicated. Regarding the treatment of complex cases, 
video-assisted thoracoscopic surgery is a promising 
technique. However, further studies are needed to as-
sess its advantages and disadvantages in comparison 
to more invasive thoracic surgery.
REFERENCES
Barrs V.R., Allan G.S., Martin P., Beatty J.A., Malik R. 
(2005). Feline pyothorax, A retrospective study of 27 
cases in Australia. Journal of Feline Medicine and Sur-
gery 7, 211-222.
Barrs V.R., Beatty J.A. (2009a). Feline pyothorax – New 
insights into an old problem: Part 1. Aethiopathogenesis 
and diagnostic investigation. The Veterinary Journal 
179, 163-170.
Barrs V.R., Beatty J.A. (2009b). Feline pyothorax - New 
insights into an old problem: Part 2. Treatment recom-
mendations and prophylaxis. The Veterinary Journal 
179, 171-178.
Bauer T. (2008). Pyothorax. In: Kirk R.W. (editor). Cur-
rent Veterinary Practice IX. Ninth edition, WB Saunders, 
Philadelphia, p. 292-295.
Beatty J.A., Barrs V. (2010). Pleural effusion in the cat. A 
practical approach to determining aetiology. Journal of 
Feline Medicine and Surgery 12, 693-707.
Boothe H.W., Howe L.M., Boothe D.M., Reynolds L.A., 
Carpenter M. (2010). Evaluation of outcomes in dogs 
treated for pyothorax, 46 cases (1983-2001). Journal of 
the American Veterinary Medical Association 236, 657-
663.
Brady C.A., Otto C.M., Van Winkle T.J., King L.G. (2000). 
Severe sepsis in cats, 29 cases (1986-1998). Journal of 
the American Veterinary Medicine Association 217, 531-
535.
Christie N.A. (2010). Management of pleural space: Effu-
sions and empyema. Surgical Clinics of North America 
90, 919-934.
Crawford A.H., Halfacree Z.J., Lee K.C.L., Brockman D.J. 
(2011). Clinical outcome following pneumectomy for 
management of chronic pyothorax in four cats. Journal 
of Feline Medicine and Surgery 13, 762-767.
Demetriou J.L., Foale R.D., Ladlow J., McGrotty Y., 
Faulkner J., Kirby B.M. (2002). Canine and feline pyo-
thorax: a retrospective study of 50 cases in the UK and 
Ireland. Journal of Small Animal Practice 43, 388-394.
Doyle R.S., Bellenger C.R., Campoy L., McAllister H. 
(2005). Pyothorax in a cat managed by intrathoracic de-
bridement and postoperative ventilary support. Irish Vet-
erinary Journal 58, 211-215.
Doyle J.L., Kuiper von Lande R.G., Worth A.J. (2009). 
Intra-thoracic pyogranulomatous disease in four working 
dogs. New Zealand Veterinary Journal 57, 346-351.
Epstein S.E. (2014). Exudative pleural disease in small ani-
mals. Veterinary Clinics of North-America: Small Animal 
Practice 44, 161-180.
Ettinger S.J., Feldman E.C. (2010). Pleural and extrapleu-
ral disease. In, L.L. Ludwig, A.M. Simpson, E. Han (edi-
tors). Textbook of Veterinary Internal Medicine. Seventh 
Edition, Volume I, Saunders Elsevier, Missouri, p. 1125-
1137.
Firth A., Boag A. (2012). Managing the dyspnoeic emer-
gency patient. In Practice 34, 564-571.
Frendin J., Obel N. (1997). Catheter drainage of pleural 
fluid collections and pneumothorax. Journal of Small 
Animal Practice 38, 237-242.
Greene C.E. (2006). Section V:, clinical problems. In: Cal-
vert C.A., Wall M. (editors). Infectious Diseases of the 
Dog and Cat. Third Edition, Saunders Elsevier, Missouri, 
p. 851.
Glowaski M.M. (2002). Analgesia in critical care. Veteri-
nary Clinics of North-America: Small Animal Practice 
32, 1127-1144.
Jiménez-Peláez M., Jolliffe C. (2012). Thoracoscopic for-
eign body removal and right middle lung lobectomy to 
treat pyothorax in a dog. Journal of Small Animal Prac-
tice 53, 240-244.
Johnson M.S., Martin M.W.S. (2007). Successful medical 
treatment of 15 dogs with pyothorax. Journal of Small 
Animal Practice 48, 12-16.
Jonas L.D. (1983). Feline pyothorax: a retrospective study 
of twenty cases. Journal of the American Animal Hospi-
tal Association 19, 865-871.
Klainbart S., Mazaki-Tovi M., Auerbach N., Aizenberg 
I., Bruchim Y., Dank G., Laby E., Aroch I., Harrus S. 
(2005). Spirocercosis-associated pyothorax in dogs. The 
Veterinary Journal 173, 209-214.
Kovak J.R., Ludwig L.L., Bergman P.J., Baer K.E., Noone 
K.E. (2002). Use of thoracoscopy to determine the etio-
logy of pleural effusion in dogs and cats: 18 cases (1998-
2001). Journal of the American Veterinary Medical As-
sociation 221, 990-994.
Kowalski S.E., Bradley B.D., Greengrass R.A., Freedman 
J., Younes M.K. (1992). Effects of interpleural bupiva-
caine (0.5%) on canine diaphragmatic function. Anaes-
thesia and Analgesia 75, 400-404.
Lee K.C.L. (2014). Surgical or medical management of 
pyothorax in dogs? Veterinary Record 174, 605-607.
Vlaams Diergeneeskundig Tijdschrift, 2017, 86 197
Lemke K.A., Dawson S.D. (2000). Local and regional an-
aesthesia. Veterinary Clinics of North America, Small 
Animal Practice 30, 839-57.
Light R.W. (2001). Parapneumonic effusions and empy-
ema. In: John J.-R., Barrett K.B., Vassiliou J.C. (editors). 
Pleural Diseases. Fourth Edition, Lippincott Williams & 
Wilkins, Philadelphia, p. 151–181. 
Love D.N., Jones R.F., Bailey M., Johnson R.S., Gamble 
N. (1982). Isolation and characterization of bacteria from 
pyothorax (empyaemia) in cats. Veterinary Microbiology 
7, 455-461.
MacPhail C.M. (2007). Medical and surgical management 
of pyothorax. Veterinary Clinics of North America: Small 
Animal Practice 37, 975-988.
Malik R., Krockenberger M.B., O’Brien C.R., White J.D., 
Foster D., Tisdall P.L.C., Gunew M., Carr P.D., Bodell 
L., McCowan C., Howe J., Oakley C., Griffin C., Wigney 
D.I., Martin P., Norris J., Hunt G., Mitchell D.H., Gilpin 
C. (2006). Nocardia infections in cats: a retrospective 
multi-institutional study of 17 cases. Australian Veteri-
nary Journal 84, 235-245.
Marques A.I.D.C., Tattersall J., Shaw D.J., Welsh E. (2009). 
Retrospective analysis of the relationship between time 
of thoracostomy drain removal and discharge time. Jour-
nal of Small Animal Practice 50, 162-166.
Mathews K., Kronen P.W., Lascelles D., Nolan A., Robert-
son S., Steagall P.V.M., Wright B., Yamashita K. (2014). 
Guidelines for recognition, assessment and treatment of 
pain. Journal of Small Animal Practice 55, E10-E68.
Mellanby R.J., Villiers E., Herrtage M.E. (2002). Canine 
pleural and mediastinal effusions: a retrospective study 
of 81 cases. Journal of Small Animal Practice 43, 447-
451.
Monnet E. (2009). Interventional thorascoscopy in small 
animals. Veterinary Clinics of North America, Small Ani-
mal Practice 39, 965-975.
Murphy K., Papasouliotis K. (2011a). Pleural effusions in 
dogs and cats. 1. Diagnostic investigation. In Practice 
33, 462-469.
Murphy K., Papasouliotis K. (2011b). Pleural effusions in 
dogs and cats. 2. Placement of tubes and treatment. In 
Practice 33, 526-530.
Nelson R.W., Couto C.G. (2014). Clinical manifestations 
of the pleural cavity and mediastinal disease. In: David-
son A.P., DiBartola S.P., Eleanor C.H., Lappin M.R., 
Scott-Moncrieff J.C., Taylor S.M., Ware W.A., Watson 
P.J., Westropp J.L., Willard M.D. (editors). Small Animal 
Internal Medicine. Fifth Edition, Saunders Elsevier, Mis-
souri, p. 337-342.
Oliveira C.R., Ranallo F.N. Pijanowski G.J., Mitchell 
M.AM, O’Brien M.A., McMichael M., Hartman S.K., 
Matheson J.S., O’Brien R.T. (2011). The VetMouse-
TrapTM: a device for computed tomographic imaging of 
the thorax of awake cats. Veterinary Radiology and Ul-
trasound 52, 41-52.
Ottenjann M., Weingart C., Arndt G., Kohn B. (2006). 
Characterization of the anemia of inflammatory disease 
in cats with abscesses, pyothorax, or fat necrosis. Journal 
of Veterinary Internal Medicine 20, 1143-1150.
Peabody J.W., Seabury J.H. (1960). Actinomycosis and no-
cardiosis, a review of basic differences in therapy. The 
American Journal of Medicine 28, 99-115.
Piek C.J., Robben J.H. (2000). Pyothorax in nine dogs. Vet-
erinary Quarterly 22, 107-111.
Rahman N.M., Gleeson F.V. (2006). New directions in the 
treatment of infected pleural effusion. Clinical Radiology 
61, 719-722.
Rooney M.B., Monnet E. (2002). Medical and surgical 
treatment of pyothorax in dogs: 26 cases (1991-2001). 
Journal of the American Veterinary Medical Association 
221, 86-92.
Schwarz T., O’Brien R. (2011). CT acquisation principles. 
In: Schwarz T., Saunders J. (editors). Veterinary Com-
puted Tomography. First edition, John Wiley and Sons 
Ltd, West Sussex, p. 25-27.
Seville R., Riha R.L., Rahman N. (2009). Pleural infection. 
Respiratory Medicine 2, 107-110.
Sigrist N., Adamik K.M., Doherr M.G., Spreng D.E. (2011). 
Evaluation of respiratory parameters at presentation as 
clinical indicators of the respiratory localization in dogs 
and cats with respiratory distress. Journal of Veterinary 
Emergency and Critical Care 21, 13-23.
Sivacolundhu R.K., O’Hara A.J., Read R.A. (2001). Tho-
racic actinomycosis (arcanobacteriosis) or nocardioses 
causing thoracic pyogranuloma formation in three dogs. 
Australian Veterinary Journal 79, 398-402.
Stein G.E., Goldstein E.J.C. (2006). Fluoroquinolones and 
anaerobes. Clinical Infectious Diseases 42, 1598–1607.
Sullivan D.C., Chapman S.W. (2010). Bacteria that mas-
querade as fungi, actinomycosis/Nocardia. In: Proceed-
ings of the American Thoracic Society 7, 216-221.
Swinbourne F., Baines E.A., Baines S.J., Halfacree Z.J. 
(2011). Computed tomographic findings in canine pyo-
thorax and correlation with findings at exploratory thora-
cotomy. Journal of Small Animal Practice 52, 203-208.
Tattersall J.A., Welsh E. (2006). Factors influencing the 
short-term outcome following thoracic surgery in 98 
dogs. Journal of Small Animal Practice 47, 715-720.
Valtolina C., Adamantos S. (2009). Evaluation of small-
bore wire-guided chest drains for management of pleural 
space disease. Journal of Small Animal Practice 50, 290-
297.
Vansteenkiste D.P., Lee K.C.L., Lamb C.R. (2014). Com-
puted tomographic findings in 44 dogs and 10 cats with 
grass seed foreign bodies. Journal of Small Animal Prac-
tice 55, 579-584.
Waddell L.S., Brady C.A., Drobatz K.J. (2002). Risk fac-
tors, prognostic indicators and outcome of pyothorax in 
cats, 80 cases (1986-1999). Journal of the American Vet-
erinary Medical Association 221, 819-824.
Walker A.L., Jang S.S., Hirsh D.C. (2000). Bacteria associ-
ated with pyothorax of dogs and cats, 98 cases (1989-
1998). Journal of the American Veterinary Medical As-
sociation 216, 359-363.
Yildiz O., Doganay M. (2006). Actinomycoses and Nocar-
dia pulmonary infections. Current Opinion in Pulmonary 
Medicine 12, 228-234.
Zoia A., Drigo M. (2016). Diagnostic value of Light’s crite-
ria and albumin gradient in classifying the pathophysio-
logy of pleural effusion formation in cats. Journal of Fe-
line Medicine and Surgery, 18, 666-672.
